Zheng Yang

1.4k total citations
60 papers, 1.0k citations indexed

About

Zheng Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zheng Yang has authored 60 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Zheng Yang's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Zheng Yang is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Zheng Yang collaborates with scholars based in China, United States and Hong Kong. Zheng Yang's co-authors include Wuning Mo, Liantang Wang, Yupeng Feng, Zunfu Ke, Junfeng Zhu, Xiaorong Huang, Junyi Zhou, Maomao Zhang, Qisheng Su and Jian Wu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zheng Yang

60 papers receiving 994 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng Yang China 17 578 477 148 124 120 60 1.0k
Qinghua Min China 13 572 1.0× 349 0.7× 65 0.4× 121 1.0× 68 0.6× 22 935
Uriel M. Malyankar United States 10 477 0.8× 247 0.5× 116 0.8× 263 2.1× 124 1.0× 12 920
Nathalie Cloutier Canada 17 929 1.6× 332 0.7× 391 2.6× 270 2.2× 160 1.3× 26 1.6k
Kazue Shimizu Japan 16 720 1.2× 189 0.4× 101 0.7× 201 1.6× 86 0.7× 29 1.3k
Mohammad Shahjahani Iran 19 580 1.0× 267 0.6× 178 1.2× 247 2.0× 45 0.4× 67 1.3k
Motozo Yamashita Japan 16 1.1k 1.9× 248 0.5× 288 1.9× 382 3.1× 88 0.7× 20 1.6k
Susanne Timshel Denmark 15 343 0.6× 364 0.8× 113 0.8× 281 2.3× 73 0.6× 20 1.1k
Lise Larsen Denmark 14 215 0.4× 153 0.3× 100 0.7× 134 1.1× 200 1.7× 15 880
Shanzhong Yang United States 16 1.0k 1.7× 758 1.6× 315 2.1× 167 1.3× 74 0.6× 21 1.6k
Xianbo Zuo China 21 391 0.7× 167 0.4× 324 2.2× 113 0.9× 81 0.7× 95 1.0k

Countries citing papers authored by Zheng Yang

Since Specialization
Citations

This map shows the geographic impact of Zheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Yang more than expected).

Fields of papers citing papers by Zheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Yang. The network helps show where Zheng Yang may publish in the future.

Co-authorship network of co-authors of Zheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Yang. A scholar is included among the top collaborators of Zheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Yang. Zheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, John B., et al.. (2025). The Role of SWI/SNF Complex in Bladder Cancer. Journal of Cellular and Molecular Medicine. 29(1). e70348–e70348. 2 indexed citations
2.
Wang, Lijun, et al.. (2025). The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies. Frontiers in Medicine. 11. 1490929–1490929. 5 indexed citations
3.
Li, Mengyu, et al.. (2024). Taurine ameliorates radiation-induced oxidative stress in bone marrow mesenchymal stromal cells and promotes osteogenesis. Free Radical Biology and Medicine. 225. 805–820. 4 indexed citations
4.
Yang, Xinyu, Yanqi Zhang, Xingyi Wang, et al.. (2024). Exercise-mediated epigenetic modifications in cardiovascular diseases. Epigenomics. 17(3). 179–191. 3 indexed citations
5.
Yang, Zheng, Shengjie Xue, Ying Tan, et al.. (2023). 1188 In vitro and in vivo characterization of CD8+ T cell engagers (TCEs) for cancer immunotherapy. SHILAP Revista de lepidopterología. A1308–A1308. 1 indexed citations
6.
Zhang, Zhengye, et al.. (2021). Stromal cell-derived factor (SDF)-1α and platelet-rich plasma enhance bone regeneration and angiogenesis simultaneously in situ in rabbit calvaria. Journal of Materials Science Materials in Medicine. 32(9). 125–125. 7 indexed citations
7.
Yang, Zheng, et al.. (2021). N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation via YAP1. Frontiers in Oncology. 11. 669731–669731. 27 indexed citations
8.
Chen, Huang, Zheng Yang, Jianhui Ma, et al.. (2021). Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer. Frontiers in Oncology. 11. 674933–674933. 14 indexed citations
9.
Yang, Zheng, Xiaohong Li, Qisheng Su, et al.. (2020). TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma. BioMed Research International. 2020(1). 3962146–3962146. 11 indexed citations
10.
Zhang, Maomao, Zheng Yang, Yong Sun, et al.. (2019). Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome. Theranostics. 9(12). 3425–3442. 106 indexed citations
11.
Li, Yinyin, Zhongyuan Lin, Xiang Shi, et al.. (2017). Retrospective analysis of 15 cases of Penicillium marneffei infection in HIV-positive and HIV-negative patients. Microbial Pathogenesis. 105. 321–325. 17 indexed citations
12.
Xu, Liang, Yu Jia, Xianghong Yang, et al.. (2017). MicroRNA-130b transcriptionally regulated by histone H3 deacetylation renders Akt ubiquitination and apoptosis resistance to 6-OHDA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(6). 1678–1689. 18 indexed citations
13.
Mo, Shi‐Jing, Jun Hong, Xu Chen, et al.. (2015). VEGF-mediated NF-κB activation protects PC12 cells from damage induced by hypoxia. Neuroscience Letters. 610. 54–59. 16 indexed citations
15.
Chen, Xu, Zhe Wang, Yulan Yan, et al.. (2014). XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis. PLoS ONE. 9(1). e84195–e84195. 24 indexed citations
16.
Yang, Zheng & Y. Hata. (2013). What is the Hippo pathway? Is the Hippo pathway conserved in Caenorhabditis elegans?. The Journal of Biochemistry. 154(3). 207–209. 16 indexed citations
17.
Chen, Xu, et al.. (2013). Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk. Tumor Biology. 35(3). 2521–2528. 7 indexed citations
18.
Yang, Zheng, Yanhong Ni, Xiaofeng Huang, Zhiyong Wang, & Wei Han. (2013). Overexpression of HIF-1α indicates a poor prognosis in tongue carcinoma and may be associated with tumour metastasis. Oncology Letters. 5(4). 1285–1289. 30 indexed citations
19.
Chen, Xu, et al.. (2013). Association of GSTP1 −313A/G polymorphisms and endometriosis risk: a meta-analysis of case–control studies. European Journal of Obstetrics & Gynecology and Reproductive Biology. 171(2). 362–367. 21 indexed citations
20.
Zhu, Junfeng, Yupeng Feng, Zunfu Ke, et al.. (2012). Down-Regulation of miR-183 Promotes Migration and Invasion of Osteosarcoma by Targeting Ezrin. American Journal Of Pathology. 180(6). 2440–2451. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026